Reneuron Group Stock Price, News & Analysis
Company Description
Reneuron Group (OTC Link: RNUGF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $62.9K.
RNUGF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of RNUGF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Reneuron Group (RNUGF) stock last traded at $0.0000. At a market capitalization of $62.9K, RNUGF is classified as a micro-cap stock with approximately 57.2M shares outstanding.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Reneuron Group (RNUGF) currently stands at 899 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Reneuron Group (RNUGF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 2.7 to 1000.0 days.
RNUGF Company Profile & Sector Positioning
Reneuron Group (RNUGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RNUGF often look at related companies in the same sector, including U S Stem Cell Inc (USRM), Syros Pharmaceut (SYRS), Aridis Pharmaceuticals Inc (ARDS), Adhera Therapeutics Inc (ATRX), and GB Sciences (GBLX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNUGF's relative position within its industry.